Chronic renal failure in diabetes: survival with hemodialysis vs. transplantation.

M A Totten, B Izenstein, R E Gleason, F J Takacs, J A Libertino, J A D'Elia
{"title":"Chronic renal failure in diabetes: survival with hemodialysis vs. transplantation.","authors":"M A Totten,&nbsp;B Izenstein,&nbsp;R E Gleason,&nbsp;F J Takacs,&nbsp;J A Libertino,&nbsp;J A D'Elia","doi":"10.3109/08860227809103861","DOIUrl":null,"url":null,"abstract":"<p><p>Clinical observations for 49 diabetic patients who required chronic hemodialysis or renal transplantation during a four year period are presented. Twenty-seven dialysis patients had a two year cumulative survival of 74% compared to 54% for 22 transplantation patients. The cumulative survival of live-related donor recipients (77%) was similar to that of the dialysis group and significantly better than that of cadaveric allograft recipients (36%). While the incidences of cardiomegaly and of motor neuropathy were high among live-related donor recipients, dialysis patients more often demonstrated peripheral vascular disease. Causes of death in hemodialysis patients included cardipulmonary arrest and patient decision to discontinue therapy; in the transplantation group included cardiopulmonary arrest, sepsis, and stroke. Living-related transplantation remains the preferred mode of therapy because of the potential for rehabilitation. In terms of patient survival, the risks of cadaver transplantation must be weighted against the discomforts of chronic dialysis.</p>","PeriodicalId":75998,"journal":{"name":"Journal of dialysis","volume":"2 1","pages":"17-32"},"PeriodicalIF":0.0000,"publicationDate":"1978-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://sci-hub-pdf.com/10.3109/08860227809103861","citationCount":"10","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Journal of dialysis","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.3109/08860227809103861","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}
引用次数: 10

Abstract

Clinical observations for 49 diabetic patients who required chronic hemodialysis or renal transplantation during a four year period are presented. Twenty-seven dialysis patients had a two year cumulative survival of 74% compared to 54% for 22 transplantation patients. The cumulative survival of live-related donor recipients (77%) was similar to that of the dialysis group and significantly better than that of cadaveric allograft recipients (36%). While the incidences of cardiomegaly and of motor neuropathy were high among live-related donor recipients, dialysis patients more often demonstrated peripheral vascular disease. Causes of death in hemodialysis patients included cardipulmonary arrest and patient decision to discontinue therapy; in the transplantation group included cardiopulmonary arrest, sepsis, and stroke. Living-related transplantation remains the preferred mode of therapy because of the potential for rehabilitation. In terms of patient survival, the risks of cadaver transplantation must be weighted against the discomforts of chronic dialysis.

糖尿病慢性肾衰竭:血液透析与移植的生存。
本文报道49例需要慢性血液透析或肾移植的糖尿病患者4年的临床观察。27例透析患者的2年累积生存率为74%,而22例移植患者的2年累积生存率为54%。活体供体受体的累积生存率(77%)与透析组相似,明显优于尸体移植受体(36%)。虽然心脏肥大和运动神经病变的发生率在活体供体受者中较高,但透析患者更常表现为周围血管疾病。血液透析患者的死亡原因包括心肺骤停和患者决定停止治疗;移植组包括心肺骤停、败血症和中风。活体相关移植仍然是首选的治疗模式,因为它具有康复的潜力。就患者生存而言,尸体移植的风险必须与慢性透析带来的不适相权衡。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 求助全文
来源期刊
自引率
0.00%
发文量
0
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:604180095
Book学术官方微信